258 related articles for article (PubMed ID: 20851186)
1. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.
Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L
Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186
[TBL] [Abstract][Full Text] [Related]
2. Effect of surface histidine mutations and their number on the partitioning and refolding of recombinant human granulocyte-colony stimulating factor (Cys17Ser) in aqueous two-phase systems containing chelated metal ions.
Zaveckas M; Zvirbliene A; Zvirblis G; Chmieliauskaite V; Bumelis V; Pesliakas H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):409-19. PubMed ID: 17339136
[TBL] [Abstract][Full Text] [Related]
3. Expression, refolding and purification of a human interleukin-17A variant.
Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
[TBL] [Abstract][Full Text] [Related]
4. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
5. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
[TBL] [Abstract][Full Text] [Related]
6. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.
Ho JG; Middelberg AP
Biotechnol Bioeng; 2004 Sep; 87(5):584-92. PubMed ID: 15352056
[TBL] [Abstract][Full Text] [Related]
7. A screening system for the identification of refolding conditions for a model protein kinase, p38alpha.
Cowan RH; Davies RA; Pinheiro TT
Anal Biochem; 2008 May; 376(1):25-38. PubMed ID: 18294951
[TBL] [Abstract][Full Text] [Related]
8. Refolding and purification of rhNTA protein by chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
[TBL] [Abstract][Full Text] [Related]
9. A purification method for improving the process yield and quality of recombinant human granulocyte colony-stimulating factor expressed in Escherichia coli and its characterization.
Rao DV; Narasu ML; Rao AK
Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):77-87. PubMed ID: 17714071
[TBL] [Abstract][Full Text] [Related]
10. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
11. Smart polymer mediated purification and recovery of active proteins from inclusion bodies.
Gautam S; Dubey P; Singh P; Kesavardhana S; Varadarajan R; Gupta MN
J Chromatogr A; 2012 Apr; 1235():10-25. PubMed ID: 22425208
[TBL] [Abstract][Full Text] [Related]
12. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
13. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
Tran-Moseman A; Schauer N; De Bernardez Clark E
Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
[TBL] [Abstract][Full Text] [Related]
14. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
Wang C; Wang L; Geng X
Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
[TBL] [Abstract][Full Text] [Related]
15. Renaturation and purification of rhGM-CSF with ion-exchange chromatography.
Bai Q; Chen G; Liu J; Geng X
Biotechnol Prog; 2007; 23(5):1138-42. PubMed ID: 17848094
[TBL] [Abstract][Full Text] [Related]
16. E. coli derived human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) available for clinical trials.
Gronski P; Badziong W; Habermann P; List W; Müllner H; Neurohr KJ; Tripier D; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):246-9. PubMed ID: 2467652
[TBL] [Abstract][Full Text] [Related]
17. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
18. Solution studies of recombinant human stromal-cell-derived factor-1.
Holmes WD; Consler TG; Dallas WS; Rocque WJ; Willard DH
Protein Expr Purif; 2001 Apr; 21(3):367-77. PubMed ID: 11281710
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro.
Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L
Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269
[TBL] [Abstract][Full Text] [Related]
20. Renaturation with simultaneous purification of rhG-CSF from Escherichia coli by ion exchange chromatography.
Wang C; Wang L; Geng X
Biomed Chromatogr; 2007 Dec; 21(12):1291-6. PubMed ID: 17634960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
